Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03417557 · ClinicalTrials.gov registry record · NA
Clinical Validation Study of Comfilcon A Multifocal Toric Contact Lenses
A NA study of Presbyopia, sponsored by CooperVision.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT03417557: Completed NA study of Presbyopia, sponsored by CooperVision.
NCT03417557 is a NA study of Presbyopia that has completed, run by CooperVision. The registered enrollment target is 20 participants, below the 270-participant average among 38 other Presbyopia trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03417557, a NA study of Presbyopia, has completed, sponsored by CooperVision.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a study to evaluate the clinical performance and subjective acceptance of an investigational contact lens (test), compared to a marketed lens (control) in an in-office setting.
Primary Outcome
Visual acuity is assessed for test and control lens on a logMAR chart
Conditions Studied
Interventions
- DEVICE Comfilcon A lens (test)
- DEVICE Omafilcon B lens (control)
Study Locations (1)
Indiana
- Clinical Optics Research Lab (CORL) Indiana University School of Optometry, Indiana University - Bloomington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2018-01-12 |
| Est. Completion | 2018-04-03 |
| Phase | NA |
What the finished NCT03417557 record still lists
NCT03417557 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 270-participant average among 38 other Presbyopia trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Presbyopia appearing as the primary indexed condition, and to 2 interventions - of which Comfilcon A lens (test) is the first listed.
NCT03417557 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT03417557 about?
NCT03417557 is a clinical study titled "Clinical Validation Study of Comfilcon A Multifocal Toric Contact Lenses". This is a study to evaluate the clinical performance and subjective acceptance of an investigational contact lens (test), compared to a marketed lens (control) in an in-office setting.
What is the current status of trial NCT03417557?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2018-01-12. Estimated completion is 2018-04-03.
What conditions does trial NCT03417557 study?
This clinical trial studies the following conditions: Presbyopia.
What interventions are being tested in trial NCT03417557?
The interventions under investigation include: Comfilcon A lens (test) (DEVICE), Omafilcon B lens (control) (DEVICE).
Who is sponsoring clinical trial NCT03417557?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03417557 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Presbyopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03417557's enrollment target sits among peer trials
20 35th of 38 higher than 3 of 38 other Presbyopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Presbyopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs
RECRUITING · NA
-
A Clinical Comparison of Proclear® 1 Day Multifocal and Clariti® 1 Day Multifocal 3 Add
RECRUITING · NA
-
Presbyopic Wear Experience With Multifocal Lenses Compared to Single Vision Lenses and Reading Glasses
RECRUITING · NA
-
Clinical Applications of Advanced Ophthalmic Imaging
RECRUITING · NA
-
Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix
ACTIVE NOT RECRUITING · NA
-
Clinical Evaluation of a Small Aperture Extended Depth of Focus Intraocular Lens
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI